Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Darzalex
Pharma
After FDA delay, Sanofi scores subcutaneous OBI nod for Sarclisa
Sanofi has gained FDA approval of its subcutaneous version of Sarclisa, which can be delivered manually or by way of an on-body injector.
Kevin Dunleavy
Jul 10, 2026 9:18am
EHA: J&J chalks up early-stage myeloma win for Talvey/Darzalex combo
Jun 13, 2026 6:00am
J&J charts speedy launch of new psoriasis pill Icotyde
Apr 14, 2026 11:43am
Orphan drug sales to surge past $400B in 2032: report
Mar 12, 2026 8:20am
J&J chief Joaquin Duato collects sizable pay raise for 2025
Mar 11, 2026 10:55am
Tecvayli-Darzalex combo earns national priority nod from FDA
Mar 6, 2026 8:00am
